March-in rights under the Bayh–Dole Act undermine the US drug development sector without lowering drug costs

Nature Biotechnology, Published online: 02 December 2025; doi:10.1038/s41587-025-02934-zMarch-in rights under the Bayh–Dole Act undermine the US drug development sector without lowering drug costs…
Read More

About The Author

Jonathan Jeriah

See author's posts